Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PHASE2 LABS, LLC

NPI: 1760077606 · NASHVILLE, TN 37217 · Clinical Medical Laboratory · NPI assigned 03/03/2021

$192K
Total Medicaid Paid
20,317
Total Claims
15,909
Beneficiaries
55
Codes Billed
2023-02
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHAYDEN, TYLER (DIRECTOR OF OPERATIONS)
NPI Enumeration Date03/03/2021

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2023 5,776 $45K
2024 14,541 $147K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 1,193 922 $65K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 1,402 1,004 $27K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 771 657 $17K
87481 745 610 $13K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 553 448 $9K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 997 790 $5K
87500 754 612 $4K
87641 710 580 $4K
87653 763 611 $4K
87563 651 540 $3K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 249 198 $3K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 249 198 $3K
87640 777 639 $3K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 180 152 $2K
80361 404 311 $2K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 272 210 $2K
80354 403 310 $1K
80372 396 304 $1K
80365 403 310 $1K
80373 397 304 $1K
80364 395 303 $1K
80347 367 278 $1K
80358 396 304 $1K
80348 390 296 $1K
80323 363 274 $1K
80333 360 272 $977.91
80338 360 271 $957.44
80370 381 290 $956.77
80335 354 266 $915.03
87631 62 55 $914.26
80345 362 274 $914.12
80349 394 300 $803.02
80355 388 296 $792.79
80366 386 294 $688.18
87581 114 95 $664.87
80324 371 282 $632.35
87486 114 95 $608.73
80360 370 281 $576.36
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 74 62 $566.87
80359 364 275 $565.47
80368 366 278 $554.06
83992 364 276 $462.19
87086 Culture, bacterial; quantitative colony count, urine 185 140 $394.39
87077 140 104 $279.73
87541 17 17 $247.29
82607 53 43 $202.48
80061 Lipid panel 74 62 $197.19
83036 Hemoglobin; glycosylated (A1C) 96 84 $149.81
80053 Comprehensive metabolic panel 90 76 $64.52
85025 Blood count; complete (CBC), automated, and automated differential WBC count 75 64 $60.38
81001 40 31 $38.39
84443 Thyroid stimulating hormone (TSH) 81 69 $36.96
36415 Collection of venous blood by venipuncture 22 17 $17.40
87632 17 17 $0.00
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 63 58 $0.00